 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cytokine
|
 |
|
Title:
|
 |
Human mip-3alpha/ccl20
|
|
Structure:
|
 |
Small inducible cytokine a20. Chain: a, b. Synonym: cc-chemokine larc, mip-3-alpha, ccl20, macrophage inflammatory protein 3 alpha, liver and activation- regulated chemokine, beta chemokine exodus-1. Engineered: yes
|
|
Source:
|
 |
Synthetic: yes. Other_details: the protein was synthesized using machine- assisted stepwise solid phase peptide synthesis on an applied biosystems 433a synthesizer using a custom- designed program tailored from the published in situ neutralization/hbtu activation protocol for boc chemistry (schnolzer, m. Et al. (1992) j.Pept.Protein res. 40, 180- 193). It is naturally found in homo sapiens (human).
|
|
Resolution:
|
 |
|
1.70Å
|
R-factor:
|
0.190
|
R-free:
|
0.238
|
|
|
Authors:
|
 |
D.M.Hoover,C.Boulegue,D.Yang,J.J.Oppenheim,K.Tucker,W.Lu, J.Lubkowski
|
Key ref:
|
 |
D.M.Hoover
et al.
(2002).
The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.
J Biol Chem,
277,
37647-37654.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
24-Jul-02
|
Release date:
|
31-Jul-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P78556
(CCL20_HUMAN) -
C-C motif chemokine 20
|
|
|
|
Seq: Struc:
|
 |
 |
 |
96 a.a.
61 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
7 terms
|
 |
|
Biochemical function
|
cytokine activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
277:37647-37654
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.
|
|
D.M.Hoover,
C.Boulegue,
D.Yang,
J.J.Oppenheim,
K.Tucker,
W.Lu,
J.Lubkowski.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human macrophage inflammatory protein-3alpha (MIP-3alpha; CCL20) is a CC-type
chemokine that binds to and activates CC chemokine receptor-6 (CCR6). Although
MIP-3alpha does not share the binding site of CCR6 with any other chemokine,
human beta-defensin-1 and -2, small cationic antimicrobial peptides, have also
been found to bind to and activate CCR6. Conversely, we have found that
MIP-3alpha possesses antibacterial activity of greater potency than human
beta-defensin-1 and -2 against Escherichia coli ATCC 25922 and Staphylococcus
aureus ATCC 29213, while having no activity against the fungus Candida albicans.
There is no clear sequence similarity between beta-defensins and the chemokine
MIP-3alpha, beyond an abundance of cationic residues and the presence of
disulfide bonds. Nonetheless, there are structural similarities between these
three proteins that allow their overlap of chemotactic and antimicrobial
activities. In this report, we describe the x-ray crystal structure of human
MIP-3alpha refined to a resolution of 1.7 A and compare it with the crystal
structures of human beta-defensin-1 and -2. Molecules of MIP-3alpha and the
beta-defensins seem to share few structural motifs that are likely associated
with their common biological activities.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Stereo drawing of the MIP-3 dimer. In
each monomer, the peptide chain begins at Asp5 and ends at
Lys65. This figure was generated using the program RIBBONS (74).
|
 |
Figure 3.
Fig. 3. Close-up stereo view of Trp55 rotated into
solvent. The interaction between crystallographically related
monomers A (shown in blue) and B (shown in red) near Trp55 is
shown. Two isopropyl alcohol molecules (ipOH) are also shown.
Leu15 rotates slightly into the pocket vacated by Trp55.
Simultaneously, the peptide between Leu15 and His16 rotates to
form a hydrogen bond with the indole nitrogen of the Trp55 side
chain. Van der Waals contacts are made between Trp55A and
Tyr58A, Ile^59A, Ile^14B, Leu54B, Trp55B, Tyr58B, and an
isopropyl alcohol molecule.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
37647-37654)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Liu,
and
E.Wilson
(2010).
The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.
|
| |
Eur J Immunol, 40,
186-196.
|
 |
|
|
|
|
 |
H.Dommisch,
W.O.Chung,
S.Jepsen,
B.M.Hacker,
and
B.A.Dale
(2010).
Phospholipase C, p38/MAPK, and NF-kappaB-mediated induction of MIP-3alpha/CCL20 by Porphyromonas gingivalis.
|
| |
Innate Immun, 16,
226-234.
|
 |
|
|
|
|
 |
S.N.Haddad,
and
C.R.Wira
(2010).
Keratinocyte Growth Factor Stimulates Macrophage Inflammatory Protein 3α and Keratinocyte-derived Chemokine Secretion by Mouse Uterine Epithelial Cells.
|
| |
Am J Reprod Immunol, 64,
197-211.
|
 |
|
|
|
|
 |
A.S.Lonsdorf,
S.T.Hwang,
and
A.H.Enk
(2009).
Chemokine receptors in T-cell-mediated diseases of the skin.
|
| |
J Invest Dermatol, 129,
2552-2566.
|
 |
|
|
|
|
 |
C.W.Lees,
and
J.Satsangi
(2009).
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history.
|
| |
Expert Rev Gastroenterol Hepatol, 3,
513-534.
|
 |
|
|
|
|
 |
K.Taylor,
M.Rolfe,
N.Reynolds,
F.Kilanowski,
U.Pathania,
D.Clarke,
D.Yang,
J.Oppenheim,
K.Samuel,
S.Howie,
P.Barran,
D.Macmillan,
D.Campopiano,
and
J.Dorin
(2009).
Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6.
|
| |
Eur J Immunol, 39,
1353-1360.
|
 |
|
|
|
|
 |
M.Ghosh,
Z.Shen,
T.M.Schaefer,
J.V.Fahey,
P.Gupta,
and
C.R.Wira
(2009).
CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract.
|
| |
Am J Reprod Immunol, 62,
60-71.
|
 |
|
|
|
|
 |
R.A.Vongsa,
N.P.Zimmerman,
and
M.B.Dwinell
(2009).
CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.
|
| |
J Biol Chem, 284,
10034-10045.
|
 |
|
|
|
|
 |
S.H.Sim,
Y.Liu,
D.Wang,
V.Novem,
S.P.Sivalingam,
T.W.Thong,
E.E.Ooi,
and
G.Tan
(2009).
Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection.
|
| |
PLoS One, 4,
e7308.
|
 |
|
|
|
|
 |
T.Hirsch,
M.Spielmann,
B.Zuhaili,
M.Fossum,
M.Metzig,
T.Koehler,
H.U.Steinau,
F.Yao,
A.B.Onderdonk,
L.Steinstraesser,
and
E.Eriksson
(2009).
Human beta-defensin-3 promotes wound healing in infected diabetic wounds.
|
| |
J Gene Med, 11,
220-228.
|
 |
|
|
|
|
 |
T.Korn,
E.Bettelli,
M.Oukka,
and
V.K.Kuchroo
(2009).
IL-17 and Th17 Cells.
|
| |
Annu Rev Immunol, 27,
485-517.
|
 |
|
|
|
|
 |
C.Weber,
S.Kraemer,
M.Drechsler,
H.Lue,
R.R.Koenen,
A.Kapurniotu,
A.Zernecke,
and
J.Bernhagen
(2008).
Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
|
| |
Proc Natl Acad Sci U S A, 105,
16278-16283.
|
 |
|
|
|
|
 |
D.I.Chan,
H.N.Hunter,
B.F.Tack,
and
H.J.Vogel
(2008).
Human macrophage inflammatory protein 3alpha: protein and peptide nuclear magnetic resonance solution structures, dimerization, dynamics, and anti-infective properties.
|
| |
Antimicrob Agents Chemother, 52,
883-894.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.O.Ochiel,
J.V.Fahey,
M.Ghosh,
S.N.Haddad,
and
C.R.Wira
(2008).
Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.
|
| |
Curr Womens Health Rev, 4,
102-117.
|
 |
|
|
|
|
 |
H.Y.Lee,
T.Takeshita,
J.Shimada,
A.Akopyan,
J.I.Woo,
H.Pan,
S.K.Moon,
A.Andalibi,
R.K.Park,
S.H.Kang,
S.S.Kang,
R.Gellibolian,
and
D.J.Lim
(2008).
Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells.
|
| |
BMC Infect Dis, 8,
87.
|
 |
|
|
|
|
 |
K.Taylor,
P.E.Barran,
and
J.R.Dorin
(2008).
Structure-activity relationships in beta-defensin peptides.
|
| |
Biopolymers, 90,
1-7.
|
 |
|
|
|
|
 |
S.Yano,
T.Banno,
R.Walsh,
and
M.Blumenberg
(2008).
Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1.
|
| |
J Cell Physiol, 214,
1.
|
 |
|
|
|
|
 |
A.Pegu,
J.L.Flynn,
and
T.A.Reinhart
(2007).
Afferent and efferent interfaces of lymph nodes are distinguished by expression of lymphatic endothelial markers and chemokines.
|
| |
Lymphat Res Biol, 5,
91.
|
 |
|
|
|
|
 |
B.E.Kim,
D.Y.Leung,
J.E.Streib,
K.Kisich,
M.Boguniewicz,
Q.A.Hamid,
and
M.D.Howell
(2007).
Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus.
|
| |
J Allergy Clin Immunol, 119,
457-463.
|
 |
|
|
|
|
 |
B.Marcet,
M.Horckmans,
F.Libert,
S.Hassid,
J.M.Boeynaems,
and
D.Communi
(2007).
Extracellular nucleotides regulate CCL20 release from human primary airway epithelial cells, monocytes and monocyte-derived dendritic cells.
|
| |
J Cell Physiol, 211,
716-727.
|
 |
|
|
|
|
 |
H.Dommisch,
W.O.Chung,
M.G.Rohani,
D.Williams,
M.Rangarajan,
M.A.Curtis,
and
B.A.Dale
(2007).
Protease-activated receptor 2 mediates human beta-defensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis.
|
| |
Infect Immun, 75,
4326-4333.
|
 |
|
|
|
|
 |
H.Goodarzi,
J.Trowbridge,
and
R.L.Gallo
(2007).
Innate immunity: a cutaneous perspective.
|
| |
Clin Rev Allergy Immunol, 33,
15-26.
|
 |
|
|
|
|
 |
J.Shi
(2007).
Defensins and Paneth cells in inflammatory bowel disease.
|
| |
Inflamm Bowel Dis, 13,
1284-1292.
|
 |
|
|
|
|
 |
L.C.Huang,
D.Jean,
R.J.Proske,
R.Y.Reins,
and
A.M.McDermott
(2007).
Ocular surface expression and in vitro activity of antimicrobial peptides.
|
| |
Curr Eye Res, 32,
595-609.
|
 |
|
|
|
|
 |
M.Zaiou
(2007).
Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.
|
| |
J Mol Med, 85,
317-329.
|
 |
|
|
|
|
 |
N.J.Wilson,
K.Boniface,
J.R.Chan,
B.S.McKenzie,
W.M.Blumenschein,
J.D.Mattson,
B.Basham,
K.Smith,
T.Chen,
F.Morel,
J.C.Lecron,
R.A.Kastelein,
D.J.Cua,
T.K.McClanahan,
E.P.Bowman,
and
R.de Waal Malefyt
(2007).
Development, cytokine profile and function of human interleukin 17-producing helper T cells.
|
| |
Nat Immunol, 8,
950-957.
|
 |
|
|
|
|
 |
N.Zhang,
Q.A.Truong-Tran,
B.Tancowny,
K.E.Harris,
and
R.P.Schleimer
(2007).
Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins.
|
| |
J Immunol, 179,
578-589.
|
 |
|
|
|
|
 |
O.Veerayutthwilai,
M.R.Byers,
T.T.Pham,
R.P.Darveau,
and
B.A.Dale
(2007).
Differential regulation of immune responses by odontoblasts.
|
| |
Oral Microbiol Immunol, 22,
5.
|
 |
|
|
|
|
 |
P.T.Liu,
S.R.Krutzik,
and
R.L.Modlin
(2007).
Therapeutic implications of the TLR and VDR partnership.
|
| |
Trends Mol Med, 13,
117-124.
|
 |
|
|
|
|
 |
E.Klüver,
K.Adermann,
and
A.Schulz
(2006).
Synthesis and structure-activity relationship of beta-defensins, multi-functional peptides of the immune system.
|
| |
J Pept Sci, 12,
243-257.
|
 |
|
|
|
|
 |
G.Entrican,
and
N.M.Wheelhouse
(2006).
Immunity in the female sheep reproductive tract.
|
| |
Vet Res, 37,
295-309.
|
 |
|
|
|
|
 |
G.Soboll,
M.A.Crane-Godreau,
M.A.Lyimo,
and
C.R.Wira
(2006).
Effect of oestradiol on PAMP-mediated CCL20/MIP-3 alpha production by mouse uterine epithelial cells in culture.
|
| |
Immunology, 118,
185-194.
|
 |
|
|
|
|
 |
M.P.Rogan,
P.Geraghty,
C.M.Greene,
S.J.O'Neill,
C.C.Taggart,
and
N.G.McElvaney
(2006).
Antimicrobial proteins and polypeptides in pulmonary innate defence.
|
| |
Respir Res, 7,
29.
|
 |
|
|
|
|
 |
Z.A.Malik,
and
B.F.Tack
(2006).
Structure of human MIP-3alpha chemokine.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 62,
631-634.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.A.Dale,
and
L.P.Fredericks
(2005).
Antimicrobial peptides in the oral environment: expression and function in health and disease.
|
| |
Curr Issues Mol Biol, 7,
119-133.
|
 |
|
|
|
|
 |
C.Esche,
C.Stellato,
and
L.A.Beck
(2005).
Chemokines: key players in innate and adaptive immunity.
|
| |
J Invest Dermatol, 125,
615-628.
|
 |
|
|
|
|
 |
C.R.Wira,
J.V.Fahey,
C.L.Sentman,
P.A.Pioli,
and
L.Shen
(2005).
Innate and adaptive immunity in female genital tract: cellular responses and interactions.
|
| |
Immunol Rev, 206,
306-335.
|
 |
|
|
|
|
 |
C.R.Wira,
K.S.Grant-Tschudy,
and
M.A.Crane-Godreau
(2005).
Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection.
|
| |
Am J Reprod Immunol, 53,
65-76.
|
 |
|
|
|
|
 |
K.Luenser,
J.Fickel,
and
A.Ludwig
(2005).
Evolution of caprine and ovine beta-defensin genes.
|
| |
Immunogenetics, 57,
487-498.
|
 |
|
|
|
|
 |
M.A.Crane-Godreau,
and
C.R.Wira
(2005).
CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys.
|
| |
Infect Immun, 73,
476-484.
|
 |
|
|
|
|
 |
M.A.Crane-Godreau,
and
C.R.Wira
(2005).
Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture.
|
| |
Infect Immun, 73,
4231-4237.
|
 |
|
|
|
|
 |
S.Z.Ding,
A.M.Torok,
M.F.Smith,
and
J.B.Goldberg
(2005).
Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection.
|
| |
Helicobacter, 10,
193-204.
|
 |
|
|
|
|
 |
T.Nakanishi,
K.Takahashi,
Y.Hosokawa,
T.Adachi,
H.Nakae,
and
T.Matsuo
(2005).
Expression of macrophage inflammatory protein 3alpha in human inflamed dental pulp tissue.
|
| |
J Endod, 31,
84-87.
|
 |
|
|
|
|
 |
D.Yang,
A.Biragyn,
D.M.Hoover,
J.Lubkowski,
and
J.J.Oppenheim
(2004).
Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.
|
| |
Annu Rev Immunol, 22,
181-215.
|
 |
|
|
|
|
 |
L.S.Ai,
S.F.Lee,
S.S.Chen,
and
F.Liao
(2004).
Molecular characterization of CCR6: involvement of multiple domains in ligand binding and receptor signaling.
|
| |
J Biomed Sci, 11,
818-828.
|
 |
|
|
|
|
 |
N.Antcheva,
M.Boniotto,
I.Zelezetsky,
S.Pacor,
M.V.Verga Falzacappa,
S.Crovella,
and
A.Tossi
(2004).
Effects of positively selected sequence variations in human and Macaca fascicularis beta-defensins 2 on antimicrobial activity.
|
| |
Antimicrob Agents Chemother, 48,
685-688.
|
 |
|
|
|
|
 |
O.L.Fahy,
S.L.Townley,
N.J.Coates,
I.Clark-Lewis,
and
S.R.McColl
(2004).
Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3alpha/CCL20.
|
| |
Lab Invest, 84,
1501-1511.
|
 |
|
|
|
|
 |
R.I.Lehrer
(2004).
Primate defensins.
|
| |
Nat Rev Microbiol, 2,
727-738.
|
 |
|
|
|
|
 |
S.Rieg,
C.Garbe,
B.Sauer,
H.Kalbacher,
and
B.Schittek
(2004).
Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions.
|
| |
Br J Dermatol, 151,
534-539.
|
 |
|
|
|
|
 |
E.Schutyser,
S.Struyf,
and
J.Van Damme
(2003).
The CC chemokine CCL20 and its receptor CCR6.
|
| |
Cytokine Growth Factor Rev, 14,
409-426.
|
 |
|
|
|
|
 |
J.J.Oppenheim,
A.Biragyn,
L.W.Kwak,
and
D.Yang
(2003).
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity.
|
| |
Ann Rheum Dis, 62,
ii17-ii21.
|
 |
|
|
|
|
 |
O.A.Asojo,
C.Boulègue,
D.M.Hoover,
W.Lu,
and
J.Lubkowski
(2003).
Structures of thymus and activation-regulated chemokine (TARC).
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
1165-1173.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Narayanan,
W.L.Miller,
and
A.M.McDermott
(2003).
Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease.
|
| |
Invest Ophthalmol Vis Sci, 44,
3795-3801.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|